Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model

Lignende værker

• Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases
  af: Sonne, Nina, et al.
  Udgivet: (2020)
• Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model
  af: Katri, Anna, et al.
  Udgivet: (2019)
• The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile
  af: Larsen, Anna Thorsø, et al.
  Udgivet: (2021)
• KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats
  af: Andreassen, K.V., et al.
  Udgivet: (2021)
• A novel dual amylin and calcitonin receptor agonist, KBP‐089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference
  af: Gydesen, Sofie, et al.
  Udgivet: (2017)